sglt2 semaglutide GLP-1, Prescriptions for Patients With T1D Increased Over Past Decade Sodium glucose CoTransporter 2 (SGLT2)

All ways of losing weight, including dieting, typically involve losing muscle mass as well as body fat

More than 88% of plans that cover Wegovy require prior authorization

In December 2025, Eli Lilly announced positive topline results from TRIUMPH-4 a 68-week Phase 3 trial in adults with obesity and knee osteoarthritis in which retatrutide delivered average weight loss of up to 71.2 lbs alongside substantial reductions in osteoarthritis pain

Research suggests that these medications may reduce the risk of heart attack and stroke in people with diabetes or obesity benefits that extend beyond weight loss alone

The goal was to create science-backed blends that felt at home in a daily routine, not a medicine cabinet